FDA Law Blog: Drug Discovery

JANUARY 4, 2023

The purpose of these town halls are to discuss topics related to OTAT-regulated products, engage with product development stakeholders, and to provide information to help stakeholders to help advance drug development. In case you do not have time to watch the town hall , we provided a summary of select topics that are discussed below.

Therapies 59

Therapies Engineering Production FDA 59

Agency IQ

NOVEMBER 10, 2023

However, FDA’s vision for OPQ to serve as a “single, agency-wide quality oversight program that applies a uniform set of standards to all regulated products, and which integrates quality review, evaluation, and inspection activities under one authority” was first publicized more than a decade earlier.

Pharmaceuticals 40

Pharmaceuticals Small Molecule Science FDA 40

The Pharma Data

SEPTEMBER 9, 2020

In order to capture and manage large amounts of data while conforming to regulations, laboratories need to transform and be digitalized by unifying data capture and providing an intuitive way of interacting with it. For further information on how we process and monitor your personal data click here.

Production 52

Production Laboratories Compliance Government 52

Agency IQ

MAY 10, 2024

The new guidance maintains the agency’s existing definitions of remanufacturing and servicing, but adds a new section that provide a high level overview of the medical device regulations – primarily for those “less familiar.” Also this year, the FDA finalized its new rule on overhauling the medical device quality system regulations.

FDA 40

FDA Regulations Compliance Production 40

Agency IQ

JULY 7, 2023

However, FDA’s vision for OPQ to serve as a “single, agency-wide quality oversight program that applies a uniform set of standards to all regulated products, and which integrates quality review, evaluation, and inspection activities under one authority” was first publicized more than a decade earlier.

Pharmaceuticals 40

Pharmaceuticals Science FDA Production 40

Agency IQ

JULY 21, 2023

BY RACHEL COE, MSC JUL 18, 2023 11:14 PM CDT Oncology endpoints: The growing pains of an evolving field FDA approval of a drug or biologic relies on whether there is “substantial evidence” of safety and effectiveness derived from “adequate and well-controlled clinical investigations” according to the Federal Food, Drug, and Cosmetic (FD&C) Act.

FDA 40

FDA Clinical Trials Treatment Trials 40

Codon

APRIL 30, 2023

Read This paper explains how synthetic biology is regulated in Europe. Read Remember all the new weight loss drugs, like tirzepatide, that celebrities are going crazy for? Well, more data is out, and people who took the drug for 72 weeks “lost up to 15.7% .” Nature Genetics. Nature Communications.

Vaccine 52

Vaccine DNA Engineering RNA 52

Codon

APRIL 30, 2023

Read This paper explains how synthetic biology is regulated in Europe. Read Remember all the new weight loss drugs, like tirzepatide, that celebrities are going crazy for? Well, more data is out, and people who took the drug for 72 weeks “lost up to 15.7% .” Nature Genetics. Nature Communications.

Vaccine 52

Vaccine DNA Engineering RNA 52

Agency IQ

APRIL 12, 2024

Landscape analysis: A look at the regulation of decentralized trials and what’s coming soon In the past few years, regulators and researchers have shown increased interest in leveraging decentralized trial methods – especially following the pandemic. At a February 2024 joint workshop with the U.S. Next, the U.S.

Regulations 40

Regulations Trials Clinical Trials Science 40

FDA Law Blog: Biosimilars

JUNE 19, 2023

Cato — The long-running saga of FDA regulation of laboratory-developed tests (LDTs) has taken yet another new turn. Over the years we have blogged many times on the twists and turns of the efforts to regulate LDTs. And regulating LDTs through guidance documents is vulnerable to legal challenge on procedural grounds.

FDA 56

FDA Regulations Laboratories Drugs 56

Agency IQ

FEBRUARY 21, 2024

Roche post-approval change submission to be first test of Accumulus Synergy’s cloud platform Although individual regulators are increasingly adopting online, cloud-based approaches to interface with sponsors, there’s been no centralized cloud platform to support efficient submissions to multiple regulators.

Science 40

Science Regulations International FDA 40

PPD

NOVEMBER 18, 2024

Regulatory oversight is foundational to the safe and effective development and commercialization of new drugs and medical devices. However, in the modern biotech and pharmaceutical industry, a PV RI team needs to do more than just monitor ever-changing regulations.

Clinical Trials 52

Clinical Trials Regulations Compliance Production 52

PPD

JANUARY 6, 2025

LLMs are a useful tool for extracting dense information contained in white papers or info-rich tables, such as a schedule of assessments. LLMs are trained using already established content, but clinical research will always consist of new drugs and therapies with a lack of pre-existing written information.

Clinical Research 52

Clinical Research Clinical Trials Compliance Engineering 52

Drug & Device Law

JULY 31, 2023

It’s an interesting topic; Eric recently wrote a paper on it , and Bexis is putting together a “white paper” for the Product Liability Advisory Council on the same subject. 2003), an Internal Revenue Service regulation, excluded liability for “product” refund, repair or replacement. at 77 (citation omitted).

Production 52

Production Trials International Government 52